Answers are grounded in this paper and cite their sources.
A series of analogues of adenine nucleotides have been synthesized and tested for Pharmacological potency and resistance to dephosphorylation at a variety of isolated tissue preparations where ATP is active. Structure-activity studies defined four subtypeso f purinoceptors, and enabled the design of specific agonists for P2x and for P2y purinoceptors to be undertaken. L-Adenosine 5′-β, γ-methylenetriphosphonate (L-AMP-PCP) is a specific P2x purinoceptor agonist, and adenosine 5′-β-fluorodiphosphate (ADP-β-F) is a specific P2y agonist.
No takes yet. Share an insight, caveat, or question.
Cusack et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: